SCHEMBL7051474

SCHEMBL7051474

CC(=O)N(c1ccc(C(F)(F)F)cc1)c1ccc(NC(=O)/C=C\c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)cc1C(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.42
KMT2A Q03164 8/20 0.42
ALDH1A1 P00352 5/20 0.42
ALOX12 P18054 1/20 0.42
RAB9A P51151 1/20 0.42
POLB P06746 2/20 0.39
MAPT P10636 5/20 0.38
TNNI3 P19429 1/20 0.37
TNNT2 P45379 1/20 0.37
TNNC1 P63316 1/20 0.37
KDM4E B2RXH2 4/20 0.37
GAA P10253 2/20 0.37
RECQL P46063 2/20 0.37
DUSP3 P51452 1/20 0.37
MAPK1 P28482 2/20 0.37
HPGD P15428 1/20 0.36
DNMT1 P26358 1/20 0.36
HTT P42858 1/20 0.36
MCL1 Q07820 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6546525 1.00 MEN1 (0.42) MEN1KMT2AALDH1A1ALOX12RAB9A
SCHEMBL6545781 0.92 MEN1 (0.46) MEN1KMT2AALDH1A1ALOX12RAB9A
SCHEMBL7054234 0.92 MEN1 (0.46) MEN1KMT2AALDH1A1ALOX12RAB9A
SCHEMBL6546039 0.91 MEN1 (0.43) MEN1KMT2AALDH1A1ALOX12RAB9A
SCHEMBL7053858 0.91 MEN1 (0.43) MEN1KMT2AALDH1A1ALOX12RAB9A
SCHEMBL7051477 0.81 KMT2A (0.45) MEN1KMT2AALDH1A1ALOX12RAB9A
SCHEMBL6545859 0.81 MAPT (0.46) MEN1KMT2AALDH1A1RAB9AMAPT
SCHEMBL6545634 0.81 MEN1 (0.46) MEN1KMT2AALDH1A1RAB9APOLB
SCHEMBL7054846 0.81 MEN1 (0.46) MEN1KMT2AALDH1A1RAB9APOLB
SCHEMBL7052138 0.81 MEN1 (0.52) MEN1KMT2AALDH1A1ALOX12RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030036532-A1 Use of 2-phenylene diamine derivatives for the treatment of infections JOMAA PHARMAKA GMBH (DE) 2003-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036532-A1 Use of 2-phenylene diamine derivatives for the treatment of infections HRH2, ASPH, NQO2 MEN1 3863/4885KMT2A 1743/4885ALDH1A1 1419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.